International Stem Cell Corporation filed its 10-K on Mar 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | 0.00% | -7.22% | +45.16% |
1st Jan change | Capi. | |
---|---|---|
+45.16% | 720K | |
+29.47% | 49.18B | |
+0.99% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.59% | 26.09B | |
-22.72% | 18.71B | |
+8.46% | 13.26B | |
+32.07% | 12.32B | |
-0.85% | 11.99B |
- Stock Market
- Equities
- ISCO Stock
- News International Stem Cell Corporation
- International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt